Navigation Links
NIH awards $6.5 million grant to UT Southwestern to develop new antibiotic
Date:3/25/2008

DALLAS March 25, 2008 Researchers at UT Southwestern Medical Center have been awarded a $6.5 million grant from the National Institute of Allergy and Infectious Diseases to develop a new anti-microbial compound to target bacterial pathogens such as Salmonella and Escherichia coli.

Though many anti-microbial drugs are available in the marketplace, new ones are needed to combat the increasing microbial resistance to antibiotics. Extensively drug-resistant tuberculosis and methicillin-resistant Staphylococcus aureus (MRSA) are two recent examples of diseases that have become increasingly difficult to treat.

This grant award represents a terrific opportunity to continue profoundly important work to develop an entirely new type of anti-microbial compound, said Dr. Michael Norgard, chairman of microbiology at UT Southwestern. With this award, the National Institutes of Health has recognized not only the importance and novelty of the project, but also the outstanding team here at UT Southwestern devoted to its successful completion.

Existing antibiotics are derived from five types of compounds, or chemical structures, and have only three targets: DNA replication in bacteria, protein synthesis and synthesis of the cell wall.

We are investigating a new target area in bacteria that appears to be vulnerable to a small molecule that has never before been used as a drug, said Dr. Vanessa Sperandio, associate professor of microbiology and principal investigator on the new grant. The drug compound has shown promise in fighting at least three different bacterial species including Salmonella, E. coli and Francisella tularensis, which causes tularemia.

Dr. Sperandio said the five-year grant will provide the necessary funding to bring her teams research up to the preclinical level.

Weve done some preliminary toxicology and the drug seems to be well tolerated, but more testing is needed to be able to say whether its sa
'/>"/>

Contact: Kristen Holland Shear
kristen.hollandshear@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

0

GOOD

Page: 1 2

Related biology news :

1. The American Society of Plant Biologists announces 2007 awards
2. Singapore National Science and Technology Awards
3. Homeland Security awards 2 grants to Rutgers for nuclear threat detection
4. NIH awards nearly $23M to University of Chicago for translational research
5. NIH awards researcher $1.5 million new innovator grant for fruit-fly studies of prion proteins
6. PETA awards $120,000 to Duluth Foundation for advancing non-animal tests
7. NIH awards UC $9 million grant to improve patient point-of-care technologies
8. NIST announces 56 new awards for innovative technology research and development
9. USP awards verified mark to Dr. Reddys Laboratories, Ltd. ingredients
10. Simons Foundation awards Emory scientists $3M for autism gene research
11. NIH grants $33 M in institutional development awards to 3 states
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NIH awards $6.5 million grant to UT Southwestern to develop new antibiotic
NIH awards $6.5 million grant to UT Southwestern to develop new antibiotic
(Date:1/7/2009)...BUS, Ohio Influenza,s ability to resist the effec...nd Russia should serve as a cautionary tale about ...nt of widespread avian flu infection in humans, sc...genome sequences of avian influenza strains to doc...e to a class of antiviral drugs called adamantanes...
(Date:1/7/2009)...) A pilot trial of an oral drug therapy called fe...d be a potential new treatment option for adult pa... the open label, single-dose study by researchers ...ty of California, Davis, Medical Center are to be ...urnal of Medical Genetics . , Results of an in...
(Date:1/7/2009)...lease is available in Spanish . , A PhD th...EHU) has studied the origin of the mutation that c...mous Community of the Basque Country there is a hi...e cases registered in the whole of Spain. , F...s considered as rare there are less than 100 case...
(Date:1/7/2009)...e, MA January 7, 2009 Phylonix Pharmaceuticals,...1,250,369 Phase II Small Business Innovation Resea...neral Medical Sciences of the National Institutes ...s for assessing drug effects on Cytochrome (CYP) P...lopment, is required by the Food and Drug Administ...
Breaking Biology News(10 mins):Study: Excessive use of antiviral drugs could aid deadly flu 2Study: Excessive use of antiviral drugs could aid deadly flu 3Study: Excessive use of antiviral drugs could aid deadly flu 4Study: Excessive use of antiviral drugs could aid deadly flu 5Promising new drug being evaluated as possible treatment option for fragile X syndrome 2Study on origin of mutation that causes fatal familiar insomnia 2Study on origin of mutation that causes fatal familiar insomnia 3NIH grants Phylonix Phase II SBIR to develop high-throughput in vivo zebrafish assays 2Compressus Next Generation MEDxConnect 28TM 29 Interoperability Solutions Feature GE Centricity and Philips iSite Integrations 30316 1Compressus Next Generation MEDxConnect 28TM 29 Interoperability Solutions Feature GE Centricity and Philips iSite Integrations 30316 2Compressus Next Generation MEDxConnect 28TM 29 Interoperability Solutions Feature GE Centricity and Philips iSite Integrations 30316 3Compressus Next Generation MEDxConnect 28TM 29 Interoperability Solutions Feature GE Centricity and Philips iSite Integrations 30316 4Vital Images and Toshiba Renew Distribution Agreement 30314 1Vital Images and Toshiba Renew Distribution Agreement 30314 2Vital Images and Toshiba Renew Distribution Agreement 30314 3Intellect Neurosciences Inc Issues Letter to Shareholders From Its Chairman and CEO 9303 1Intellect Neurosciences Inc Issues Letter to Shareholders From Its Chairman and CEO 9303 2Intellect Neurosciences Inc Issues Letter to Shareholders From Its Chairman and CEO 9303 3Intellect Neurosciences Inc Issues Letter to Shareholders From Its Chairman and CEO 9303 4Intellect Neurosciences Inc Issues Letter to Shareholders From Its Chairman and CEO 9303 5MediConnect Participates in 2008 National Health Summit 30308 1MediConnect Participates in 2008 National Health Summit 30308 2
...caused by a combination of both genetic and enviro... to be involved in at least 5?0 per cent of all ca...t cancer susceptibility genes BRCA1 and BRCA2 only...ific female breast cancer, which suggests the cont...ding to Dr Robert Winqvist, who coordinates the re...
...Kroenke, M.D., of the Indiana University School of...rts that nearly 20 percent of patients seen by pri...order. The study outlines the effectiveness of a n...e physicians to those patients with one or more an...rch 6 issue of the Annals of Internal Medicine. , ...
...almost uniformly fatal disease regardless of the s...tage of patients develop a form of ductal adenocar...detected earlier, is less aggressive and has a 50 ... pancreatic cancer behaves differently, despite ca...e common and deadly type of ductal pancreatic canc...
...ps has added another level of complexity to farmin...thropologist at Washington University in St. Louis...gy and of environmental studies, both in Arts &... has completed the first detailed anthropological ...and are impacted by ?local culture. , The study,...
Other Biology News:Gene elevating breast cancer risk also causes prostate cancer 2Anxiety disorders surprisingly common yet often untreated 2Genetic pathways to curable and incurable forms of pancreatic cancer identified 2Genetic pathways to curable and incurable forms of pancreatic cancer identified 3New technologies coming too fast for Indian farmers 2
(Date:1/7/2009)... , SOUTH SAN FRANCISCO, Calif., Jan. 7 /PRN...c. (Nasdaq: PARD ), a biopharmaceutical company ...nnounced that the Company will present,data from ...at two upcoming,American Society of Clinical Onco...pany will present updated data from its Phase 2 tr...
(Date:1/7/2009)... , UNION CITY, Calif., Jan. 7 /PRNewswire-First... products company manufacturing point-of-care bloo...terinary markets, announced today that it has ente...dwide rights in the field of animal health diagnos...echnologies pertaining to lateral flow immunoassay...
(Date:1/6/2009)... , A team of University of Toronto physicists hav...to the fundamental quantum limit, a ,finding that...easurement, next-generation atomic clocks, novel q...tanding of the universe. , Krister Shalm, Rob Ad...nt of Physics and Centre for Quantum Information a...
(Date:1/6/2009)... , INDIANAPOLIS, Jan. 6 The...ay (R) Ion Source users now have the capability to...compatible with third party,software using FireFl...s a software program that extracts and builds data...BioSystems proprietary data conversion,algorithms...
Breaking Biology Technology:Poniard Pharmaceuticals to Present Data from Phase 2 Clinical Trials of Picoplatin in Colorectal and Prostate Cancers 2Poniard Pharmaceuticals to Present Data from Phase 2 Clinical Trials of Picoplatin in Colorectal and Prostate Cancers 3ABAXIS Announces Worldwide Animal Health Licensing Agreement for Rapid Test Technology 2ABAXIS Announces Worldwide Animal Health Licensing Agreement for Rapid Test Technology 3U of T physicists squeeze light to quantum limit 2U of T physicists squeeze light to quantum limit 3Prosolia and Indigo BioSystems Come Together to Create FireFly(TM) Data Conversion Software for Mass Spectrometers 2Prosolia and Indigo BioSystems Come Together to Create FireFly(TM) Data Conversion Software for Mass Spectrometers 3
...Weston, Wis. - Tanya Townsend didn,t have much t...n,t dreading it, either. , ,How many other informa...tart fresh with a new building, new network archit...y, and when the still-to-be completed Saint Clare...echnology executive in 2004, Townsend beat out all...
...or the millions of Americans whose vision is slowl...the lowly neural progenitor cell may be riding to ...or cells derived from human fetal stem cells have ...egenerative eye disease similar to the kinds of di...in the journal Public Library of Science (PLoS) ...
... The National Cancer Institute has awarded a fiv... College of Wisconsin to study the growth of bloo...uccessful renewal of the grant that was first awar...or of radiology, is the ongoing principal investig...g what they call magnetic resonance imaging contra...
... kind of traveling road show is making its way aro...ost controversial areas of scientific research - e...elieve even the skeptics are walking away a little..., president of the Wisconsin Technology Council ,...WiCell Research Institute , are being made on beha...
Other Biology Technology:CIO Leadership Series: Tanya Townsend, Saint Clare's Hospital 2CIO Leadership Series: Tanya Townsend, Saint Clare's Hospital 3CIO Leadership Series: Tanya Townsend, Saint Clare's Hospital 4CIO Leadership Series: Tanya Townsend, Saint Clare's Hospital 5Stem cell therapy shows visionary promise 2Stem cell therapy shows visionary promise 3Traveling stem cell show continues state tour 2Traveling stem cell show continues state tour 3
...d Deletion Machine is based on the simple, higheff...d by Goryshin and Reznikoff, and by York et al. fo...nversions by intramolecular transposition into DNA... vector. Although most researchers will be interes...
...out or alter genes on the E.coli chromosome in l... exchange of genetic information in a base pair pr...ed kanamycin resistance marker cassette is supplie... on the E.coli chromosome. Red/ET recombination ...
5X StabilCoat Immunoassay Stabilizer is a 5X concentrate solution of StabilCoat Immunoassay Stabilizer. The shelf-life of 5X StabilCoat Immunoassay Stabilizer is 2 years when stored at 4C. Product
Monoclonal antibodies conjugated with rhodamine
Biology Products: